Potential mechanisms and targeting strategies of the gut microbiota in antitumor immunity and immunotherapy
Immunity, Inflammation and Disease · 2024
DOI: 10.1002/iid3.1263 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Qian Yin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Immunotherapy, Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Anti-Cancer Association-Qilu Clinical Research, Zhejiang Provincial Natural Science Foundation of China, Special Research Support for Post-marketing Clinical Research of Innovative Drugs.
Abstract (Originalsprache)
Background
Immunotherapies, notably immune checkpoints inhibitors that target programmed death 1/programmed death ligand 1(PD‐1/PD‐L1) and cytotoxic T lymphocyte‐associated antigen 4 (CTLA‐4), had profoundly changed the way advanced and metastatic cancers are treated and dramatically improved overall and progression‐free survival.
Aims
This review article aimed to explore the underlying molecular mechanisms by which the gut microbiota affects antitumor immunity and the efficacy of cancer immunotherapy.
Methods
We summarized the latest knowledge supporting the associations among the gut microbiota, antitumor immunity, and immunotherapy. Moreover, we disscussed the therapeutic strategy for improving immunotherapy efficacy by modulating gut microbiota in cancer treatment.
Results
The potential molecular mechanisms underlying these associations are explained in terms of four aspects: immunomodulation, molecular mimicry, mamps, and microbial metabolites.
Conclusion
The gut microbiota significantly impacts antitumor immunity and alters the effectiveness of cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Postgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, China.
- Department of Hepato-Pancreato-Biliary & Gastric Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
ORCID-Profile: Qian Yin
Förderung
- Zhejiang Anti-Cancer Association-Qilu Clinical Research
- Zhejiang Provincial Natural Science Foundation of China
- Special Research Support for Post-marketing Clinical Research of Innovative Drugs
- China Postdoctoral Science Foundation
Zitieren
APA
Yin, Q., Ni, J. J., & Ying, J. E. (2024). Potential mechanisms and targeting strategies of the gut microbiota in antitumor immunity and immunotherapy. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.1263
Vancouver
Yin Q, Ni JJ, Ying JE. Potential mechanisms and targeting strategies of the gut microbiota in antitumor immunity and immunotherapy. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.1263
BibTeX
@article{Yin2024,
author = {Yin, Qian and Ni, Jiao-Jiao and Ying, Jie-Er},
title = {Potential mechanisms and targeting strategies of the gut microbiota in antitumor immunity and immunotherapy},
journal = {Immunity, Inflammation and Disease},
year = {2024},
doi = {10.1002/iid3.1263}
}
EUVIMED